Lophora Raises $3 million and Recieves Approval from EMA to Initiate Phase I Clinical Trial for LPH-5
Lophora featured in Medwatch (in Danish) Read the article
Companies attract venture funding for redesigned psychedelic drugs
CSO Jesper L. Kristensen comments on the advantageous position of LPH-5 in the landscape of next generation psychedelics. Read the article
Next-generation psychedelics: should new agents skip the trip?
CSO Jesper L. Kristensen comments on the advantageous position of LPH-5 inthe landscape of next generation psychedelics. https://www.nature.com/articles/s41587-024-02285-1
Lophora collaborates with Beckley Psytech
Lophora has entered into a research and development collaboration with Beckley Psytech Limited. Read the article